Ozempic-maker Novo Nordisk ousts CEO after shares plummet

The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down following a plunge in the company's share price, the drug maker said on Friday.